as1411
Nucleic acidexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2003 (NCT00881244)
Timeline
Indications
Mechanism of action
- Apoptosis regulator Bcl-2INHIBITOR
BCL2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- agro100
- agro100
- agro100
- agro 100
- agro-100
- as1411
- as1411
- as1411
- as1411
- as 1411
- as-1411
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01034410 | Phase 2 | Jan 1, 2010 | Antisoma Research, Medical University of South Carolina |
| NCT00740441 | Phase 2 | Aug 1, 2008 | Antisoma Research, Medical University of South Carolina, Saint Francis Memorial Hospital |
| NCT00512083 | Phase 2 | Jul 1, 2007 | Antisoma Research |
| NCT00881244 | Phase 1 | Sep 1, 2003 | Antisoma Research |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Antisoma Research | For profit | 4 | 4 | 2 | 2003 |
| Medical University of South Carolina | Academic/Hospital | 2 | 0 | 1 | 2008 |
| Saint Francis Memorial Hospital | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1